Bank of New York Mellon’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $340K | Buy |
72,437
+14,126
| +24% | +$66.4K | ﹤0.01% | 3717 |
|
|
2025
Q1 | $213K | Sell |
58,311
-1
| -0% | -$4 | ﹤0.01% | 3846 |
|
|
2024
Q4 | $275K | Buy |
58,312
+1,965
| +3% | +$9.28K | ﹤0.01% | 3801 |
|
|
2024
Q3 | $525K | Sell |
56,347
-23,086
| -29% | -$215K | ﹤0.01% | 3485 |
|
|
2024
Q2 | $457K | Buy |
79,433
+18,664
| +31% | +$107K | ﹤0.01% | 3618 |
|
|
2024
Q1 | $408K | Buy |
60,769
+3,571
| +6% | +$24K | ﹤0.01% | 3641 |
|
|
2023
Q4 | $369K | Sell |
57,198
-13,534
| -19% | -$87.3K | ﹤0.01% | 3708 |
|
|
2023
Q3 | $354K | Sell |
70,732
-1,055
| -1% | -$5.28K | ﹤0.01% | 3730 |
|
|
2023
Q2 | $505K | Buy |
71,787
+755
| +1% | +$5.32K | ﹤0.01% | 3582 |
|
|
2023
Q1 | $440K | Sell |
71,032
-16
| -0% | -$99 | ﹤0.01% | 3546 |
|
|
2022
Q4 | $453K | Buy |
71,048
+4,811
| +7% | +$30.7K | ﹤0.01% | 3588 |
|
|
2022
Q3 | $569K | Buy |
66,237
+15,254
| +30% | +$131K | ﹤0.01% | 3507 |
|
|
2022
Q2 | $693K | Sell |
50,983
-10,130
| -17% | -$138K | ﹤0.01% | 3395 |
|
|
2022
Q1 | $931K | Sell |
61,113
-40,326
| -40% | -$614K | ﹤0.01% | 3360 |
|
|
2021
Q4 | $2.32M | Buy |
101,439
+48,321
| +91% | +$1.1M | ﹤0.01% | 2899 |
|
|
2021
Q3 | $740K | Buy |
53,118
+1,699
| +3% | +$23.7K | ﹤0.01% | 3573 |
|
|
2021
Q2 | $549K | Buy |
51,419
+31,979
| +165% | +$341K | ﹤0.01% | 3723 |
|
|
2021
Q1 | $256K | Buy |
19,440
+1,354
| +7% | +$17.8K | ﹤0.01% | 3965 |
|
|
2020
Q4 | $367K | Buy |
+18,086
| New | +$367K | ﹤0.01% | 3751 |
|